Related Experiment Videos
Bronchiectasis in hypogammaglobulinaemia--a computed tomography assessment.
J J Curtin1, A D Webster, J Farrant
1Radiology Department, Northwick Park Hospital, Middlesex.
Clinical Radiology
|August 1, 1991
Summary
Hypogammaglobulinaemia patients often develop bronchiectasis, primarily in the middle and lower lung lobes. Bronchial wall thickening may precede bronchiectasis development in these individuals.
Area of Science:
- Pulmonology
- Immunology
Background:
- Hypogammaglobulinaemia is associated with an increased risk of respiratory infections and complications.
- Bronchiectasis, a chronic lung condition, is a known complication in patients with primary immunodeficiencies.
Purpose of the Study:
- To investigate the characteristic patterns of bronchiectasis in patients with hypogammaglobulinaemia.
- To explore the relationship between bronchial wall thickening and bronchiectasis in this patient population.
- To compare the age of onset of bronchiectasis in X-linked agammaglobulinaemia versus common variable hypogammaglobulinaemia.
Main Methods:
- Retrospective review of CT scans from 38 patients diagnosed with hypogammaglobulinaemia.
- Analysis of the location and pattern of bronchiectasis and bronchial wall thickening.
- Comparison of bronchiectasis onset age between X-linked agammaglobulinaemia (XLA) and common variable hypogammaglobulinaemia (CVH) patients.
Main Results:
- Twenty-two of 38 patients had bronchiectasis; seven showed bronchial wall thickening without bronchiectasis.
- The middle lobe was the most frequently affected site, followed by lower lobes and lingula; no isolated upper lobe involvement was observed.
- Patients with XLA developed bronchiectasis at a significantly younger age than those with CVH (P = 0.02).
Conclusions:
- Bronchiectasis in hypogammaglobulinaemia commonly affects the middle and lower lung lobes.
- Bronchial wall thickening may represent an early inflammatory stage preceding bronchiectasis in these patients.
- XLA is associated with an earlier onset of bronchiectasis compared to CVH, irrespective of initial immunoglobulin levels.